Study: Generic nifedipine product not bioequivalent to Adalat XL

Links shared publicly online about this topic.

1,407
total visits

Study: Generic nifedipine product not bioequivalent to Adalat XL

An extended release generic nifedipine product (Mylan-Nifedipine extended release 60 mg formerly Gen-Nifedipine extended release 60mg, Genpharm ULC) is not bioequivalent to the Canadian originator product, Adalat(R) XL(R), according to the results of a study recently published in the International Journal of Clinical Pharmacology and Therapeutics.

View full resource at news-medical.net

Tags: High Blood Pressure Medication, Pregnancy, Calcium Channel Blocker, Adalat, Procardia

Most Recently Shared on February 4, 2010 at 6:52 am By:

News-Medical.Net

Pregnancy News: Study: Generic nifedipine product not bioequivalent to Adalat XL: An extended release generic nife... http://bit.ly/c5EgKg

2 years ago...

Retweet

Favorite

Bayer's Adalat XL product and Mylan's nifedipine extended release 60 mg not bioequivalent: Study

news-medical.net — “Bayer Inc. today responded to Professor Marvin Meyer's letter to the editor, entitled: "Critical questions concerning the validity of the Bayer study report of differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration" and published in the online edition of the International Journal of Clinical Pharmacology and Therapeutics. Bayer responded to the clinical relevance of the differences in formulation and dissolution behaviou” View full resource at news-medical.net